Egor Kulkov is a Russian businessman and billionaire whose fortune is rooted in the pharmaceutical industry. He is the co-founder of Pharmstandard, now Russia's leading pharmaceutical firm. His background is highly educated and industrial: he holds a Master of Science degree from Novosibirsk State University.

Kulkov's career began in finance and investment in the turbulent 1990s post-Soviet economy. In 1994, he co-founded the investment company Profit House, and later worked at SBS-Agro Bank, gaining crucial experience in corporate finance and investment strategy. This experience positioned him for the massive opportunity in consolidating Russia's fragmented pharmaceutical manufacturing base.

Egor Kulkov co-founded Pharmstandard in 2003 with Viktor Kharitonin and backing from Roman Abramovich, among others. The company was created by combining five factories bought from ICN Pharmaceuticals, recognizing the potential for scale and modernization in Russian drug manufacturing. Kulkov and Kharitonin later bought out their partners in 2008, securing a controlling stake.

Pharmstandard grew into the leading pharmaceutical firm in Russia, focusing on both generic and proprietary drug development (including being one of the makers of the Sputnik V COVID vaccine). Kulkov maintains a stake in, and sits on the board of, Pharmstandard and related Russian pharma firms like OTCPharm, Biocad, and Generium. He also became the largest shareholder of the British medical technology firm, CMR Surgical (maker of the Versius surgical robotic system), demonstrating a strategic diversification into high-tech medical devices.

Egor Kulkov's social impact is massive and structural, stemming from Pharmstandard's role in supplying essential medicines and its pivotal role in national healthcare (e.g., manufacturing the Sputnik V vaccine). The company provides thousands of stable jobs in manufacturing and R&D.

His structural contribution is tied to the modernization and scaling of the Russian pharmaceutical industry, making it more self-sufficient. His investment in CMR Surgical contributes to the advancement of medical robotics globally.

Egor Kulkov maintains the professional, composed style of a Russian industrial executive. His attire is consistently formal and high-quality, favoring tailored business suits. His aesthetic is one of serious authority and stability, befitting a multi-billionaire commanding a massive pharmaceutical empire.

Residing in Grimisuat, Switzerland, his luxury is the immense security and financial reward derived from his dominance in the pharmaceutical sector. His life is dedicated to industrial consolidation, high-tech investment, and the management of his diverse medical and real estate assets.